COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,120 | +17.0% | 2,556 | +12.5% | 0.00% | – |
| Q2 2023 | $48,819 | -56.3% | 2,272 | -51.2% | 0.00% | – |
| Q1 2023 | $111,588 | +140.0% | 4,652 | +132.1% | 0.00% | – |
| Q4 2022 | $46,493 | +45.3% | 2,004 | -1.8% | 0.00% | – |
| Q3 2022 | $32,000 | -23.8% | 2,040 | -13.7% | 0.00% | – |
| Q2 2022 | $42,000 | -8.7% | 2,363 | +5.6% | 0.00% | – |
| Q1 2022 | $46,000 | +170.6% | 2,238 | +142.7% | 0.00% | – |
| Q4 2021 | $17,000 | -5.6% | 922 | 0.0% | 0.00% | – |
| Q3 2021 | $18,000 | -18.2% | 922 | 0.0% | 0.00% | – |
| Q2 2021 | $22,000 | 0.0% | 922 | 0.0% | 0.00% | – |
| Q1 2021 | $22,000 | -42.1% | 922 | -51.2% | 0.00% | – |
| Q4 2020 | $38,000 | – | 1,888 | +7766.7% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 24 | -100.0% | 0.00% | -100.0% |
| Q3 2019 | $7,926,000 | -12.7% | 690,460 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $9,079,000 | -13.1% | 690,460 | +0.0% | 0.00% | 0.0% |
| Q1 2019 | $10,453,000 | -11.8% | 690,426 | -0.0% | 0.00% | -50.0% |
| Q4 2018 | $11,855,000 | +15.5% | 690,448 | -0.9% | 0.00% | +100.0% |
| Q3 2018 | $10,264,000 | -48.1% | 696,372 | -16.1% | 0.00% | -50.0% |
| Q2 2018 | $19,794,000 | -6.7% | 829,951 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $21,205,000 | +159.6% | 829,951 | +87.6% | 0.00% | +200.0% |
| Q4 2017 | $8,169,000 | +196.7% | 442,500 | +101.1% | 0.00% | – |
| Q2 2017 | $2,753,000 | +24.4% | 220,043 | +0.0% | 0.00% | – |
| Q1 2017 | $2,213,000 | -84.5% | 220,000 | -76.0% | 0.00% | -100.0% |
| Q4 2016 | $14,257,000 | -2.9% | 915,673 | +20.2% | 0.00% | 0.0% |
| Q3 2016 | $14,678,000 | +54.4% | 762,073 | -5.0% | 0.00% | +100.0% |
| Q2 2016 | $9,508,000 | -6.5% | 802,373 | +43.2% | 0.00% | 0.0% |
| Q1 2016 | $10,169,000 | -36.2% | 560,300 | -3.4% | 0.00% | -50.0% |
| Q4 2015 | $15,950,000 | +60.3% | 580,000 | +28.9% | 0.00% | +100.0% |
| Q3 2015 | $9,950,000 | +23.9% | 450,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $8,028,000 | – | 450,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
| Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
| Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
| GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
| RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
| Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
| CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
| EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
| ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |